Skip to main content
. 2016 Nov 25;8(3):4760–4772. doi: 10.18632/oncotarget.13587

Figure 5. Raji, Daudi, Jurkat and CEM cell growth inhibition.

Figure 5

Cell proliferation inhibition was measured 24, 48, and 72 h after treatment with DOX, DOX + rituximab, DMs + US, RDMs + US, and RDMs + US + rituximab via CCK8 assay. Data are represented as means ± SD (n=3). *P<0.05 compared with RDM + US.